BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals has informed the stock exchange that the trading window for its securities will remain closed for all designated persons and their immediate relatives starting July 1, 2025. The window will stay shut until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2025 (Q1 FY26). This is a routine compliance measure under SEBI's Insider Trading Regulations to prevent insider trading ahead of financial results. The date of the board meeting to approve the Q1 results has not yet been announced and will be communicated later.
This is a standard regulatory announcement and does not directly impact shareholders. It signals that Q1 FY26 earnings results are expected soon, which could be a near-term catalyst for the stock. Designated insiders cannot trade during this blackout period.